New research from the Snow Center for Immune Health is challenging long-held assumptions about autoimmune disease, revealing ...
On February 13, Allogene Therapeutics published new long-term follow-up data on cemacabtagene ansegedleucel, showing the investigative allogeneic chimeric antigen receptor (CAR) T-cell therapy ...
In the setting of Alzheimer’s and other neurodegenerative diseases, do T cells make things better, or worse? A simple answer just won’t do—it likely depends on the type of T cells, where they are in ...
CAR T-cell therapy has been hugely successful in treating certain types of tumours, and stiffening up cancer cells beforehand could make it even more effective ...
It develops from the abnormal multiplication of T cells, or T-lymphocytes, a type of white blood cell essential for immune system function. The specific treatment course and prognosis for T-cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results